Single-nucleotide polymorphisms in cachexia-related genes: Can they optimize the treatment of cancer cachexia?
作者信息
Ishida Junichi, Saitoh Masakazu, Springer Jochen
机构信息
Innovative Clinical Trials, Department of Cardiology and Pneumology, University Medical Centre Göttingen, Göttingen, Germany.
出版信息
J Cachexia Sarcopenia Muscle. 2017 Jun;8(3):516-517. doi: 10.1002/jcsm.12214.
Abstract
摘要
相似文献
1
Single-nucleotide polymorphisms in cachexia-related genes: Can they optimize the treatment of cancer cachexia?
J Cachexia Sarcopenia Muscle. 2017 Jun;8(3):516-517. doi: 10.1002/jcsm.12214.
2
New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss.
J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):122-130. doi: 10.1002/jcsm.12138. Epub 2016 Aug 5.
3
Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials.
Support Care Cancer. 2017 Feb;25(2):365-369. doi: 10.1007/s00520-016-3402-0. Epub 2016 Sep 15.
4
Tissue-specific dysregulation of mitochondrial respiratory capacity and coupling control in colon-26 tumor-induced cachexia.
Am J Physiol Regul Integr Comp Physiol. 2019 Jul 1;317(1):R68-R82. doi: 10.1152/ajpregu.00028.2019. Epub 2019 Apr 24.
5
Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?
BMC Cancer. 2016 Feb 8;16:75. doi: 10.1186/s12885-016-2121-8.
6
Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies.
J Genet. 2014 Dec;93(3):893-916. doi: 10.1007/s12041-014-0405-9.
7
Muscle Atrophy in Cancer.
Adv Exp Med Biol. 2018;1088:329-346. doi: 10.1007/978-981-13-1435-3_15.
8
Polymorphisms in folic acid metabolism genes do not associate with cancer cachexia in Japanese gastrointestinal patients.
Nagoya J Med Sci. 2018 Nov;80(4):529-539. doi: 10.18999/nagjms.80.4.529.
9
Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade.
Am J Physiol Endocrinol Metab. 2019 May 1;316(5):E852-E865. doi: 10.1152/ajpendo.00526.2018. Epub 2019 Mar 12.
10
Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice.
Eur J Pharmacol. 2014 Nov 15;743:1-10. doi: 10.1016/j.ejphar.2014.09.025. Epub 2014 Sep 23.
引用本文的文献
1
Characterization of cachexia in the human fibrosarcoma HT-1080 mouse tumour model.
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1813-1829. doi: 10.1002/jcsm.12618. Epub 2020 Sep 13.
本文引用的文献
1
Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-α agents in rheumatic diseases; A systematic review and meta-analysis.
J Autoimmun. 2017 May;79:4-16. doi: 10.1016/j.jaut.2017.02.003. Epub 2017 Feb 13.
2
New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss.
J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):122-130. doi: 10.1002/jcsm.12138. Epub 2016 Aug 5.
3
Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases.
World J Gastroenterol. 2016 Nov 14;22(42):9300-9313. doi: 10.3748/wjg.v22.i42.9300.
4
Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016.
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):507-509. doi: 10.1002/jcsm.12167. Epub 2016 Nov 2.
5
Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial).
J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):355-65. doi: 10.1002/jcsm.12126. Epub 2016 Jul 1.
6
Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine.
J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):449-57. doi: 10.1002/jcsm.12097. Epub 2016 Jan 5.
7
Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):555-566. doi: 10.1002/jcsm.12116. Epub 2016 Apr 7.
8
Anti-sarcopenic effects of diamino-diphenyl sulfone observed in elderly female leprosy survivors: a cross-sectional study.
J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):322-9. doi: 10.1002/jcsm.12074. Epub 2015 Oct 15.
9
Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment.
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):303-11. doi: 10.1002/jcsm.12082. Epub 2015 Nov 18.
10
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015.
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):315-6. doi: 10.1002/jcsm.12089. Epub 2015 Nov 11.
Zotero 插件